Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01629862 · ClinicalTrials.gov registry record · Phase 2
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
A Phase 2 study, sponsored by Sanjay R Patel.
- Completed
- Registry status
- Phase 2
- Development phase
- 53
- Enrollment target
NCT01629862: Completed Phase 2 study, sponsored by Sanjay R Patel.
NCT01629862 is a Phase 2 study that has completed, run by Sanjay R Patel. The registered enrollment target is 53 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01629862, a Phase 2 study, has completed, sponsored by Sanjay R Patel.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 53 participants
- Enrollment target
Study Summary
The investigators will examine the possible synergistic effects of obstructive sleep apnea (OSA) and type II diabetes mellitus (DM) on vascular functioning by performing a two-part investigation: * A cross-sectional study comparing subjects with OSA+DM, OSA only, DM only, and healthy controls. * A three-month randomized placebo-controlled trial of continuous positive airway pressure (CPAP) in subjects with OSA+DM.
Primary Outcome
Brachial artery flow-mediated dilation is measured as the percent change in brachial artery diameter post-occlusion relative to pre-occlusion. The change in brachial artery flow mediated dilation is the difference in this percent change at 3-months compared to baseline.
Interventions
- DEVICE Continuous positive airway pressure
- DEVICE Sham continuous positive airway pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2012-04 |
| Est. Completion | 2017-02 |
| Phase | Phase 2 |
What the finished NCT01629862 record still lists
NCT01629862 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 2 interventions - of which Continuous positive airway pressure is the first listed.
NCT01629862 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01629862 about?
NCT01629862 is a clinical study titled "Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea". The investigators will examine the possible synergistic effects of obstructive sleep apnea (OSA) and type II diabetes mellitus (DM) on vascular functioning by performing a two-part investigation: * A cross-sectional study comparing subjects with OSA+DM, OSA only, DM only, and healthy controls. * A ...
What is the current status of trial NCT01629862?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2012-04. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01629862?
The interventions under investigation include: Continuous positive airway pressure (DEVICE), Sham continuous positive airway pressure (DEVICE).
Who is sponsoring clinical trial NCT01629862?
This trial is sponsored by Sanjay R Patel, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01629862's enrollment target sits among peer trials
53 1171st of 2000 higher than 820 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia